company background image
EMO logo

EM Systems DB:EMO Stock Report

Last Price

€3.82

Market Cap

€276.7m

7D

-3.0%

1Y

-25.1%

Updated

25 Apr, 2024

Data

Company Financials +

EMO Stock Overview

EM Systems Co., Ltd., together with its subsidiaries, develops and sells various IT systems for pharmacies, clinics, and care/welfare other business in Japan.

EMO fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance4/6
Financial Health5/6
Dividends4/6

EM Systems Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for EM Systems
Historical stock prices
Current Share PriceJP¥3.82
52 Week HighJP¥5.75
52 Week LowJP¥3.68
Beta0.41
1 Month Change-9.48%
3 Month Change-8.61%
1 Year Change-25.10%
3 Year Change-36.33%
5 Year Change-34.41%
Change since IPO100.39%

Recent News & Updates

Recent updates

Shareholder Returns

EMODE Healthcare ServicesDE Market
7D-3.0%-2.5%0.5%
1Y-25.1%-25.2%1.3%

Return vs Industry: EMO matched the German Healthcare Services industry which returned -24.3% over the past year.

Return vs Market: EMO underperformed the German Market which returned 2.3% over the past year.

Price Volatility

Is EMO's price volatile compared to industry and market?
EMO volatility
EMO Average Weekly Movement4.5%
Healthcare Services Industry Average Movement3.9%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: EMO has not had significant price volatility in the past 3 months.

Volatility Over Time: EMO's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1980811Hiromasa Kunimitsuwww.emsystems.co.jp

EM Systems Co., Ltd., together with its subsidiaries, develops and sells various IT systems for pharmacies, clinics, and care/welfare other business in Japan. The company operates through Dispensing System Business, Medical System Business, Nursing Care/Welfare System Business, and Other Business segments. It develops and sells IT systems for pharmacies, such as medical fee receipt computers and electronic medication record systems; IT systems for clinics, including medical accounting and electronic medical record systems; and office processing systems for care/welfare providers.

EM Systems Co., Ltd. Fundamentals Summary

How do EM Systems's earnings and revenue compare to its market cap?
EMO fundamental statistics
Market cap€276.71m
Earnings (TTM)€11.75m
Revenue (TTM)€121.92m

23.5x

P/E Ratio

2.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EMO income statement (TTM)
RevenueJP¥20.36b
Cost of RevenueJP¥10.43b
Gross ProfitJP¥9.92b
Other ExpensesJP¥7.96b
EarningsJP¥1.96b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 14, 2024

Earnings per share (EPS)27.86
Gross Margin48.74%
Net Profit Margin9.64%
Debt/Equity Ratio12.1%

How did EMO perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

66%

Payout Ratio

Does EMO pay a reliable dividends?

See EMO dividend history and benchmarks
When do you need to buy EMO by to receive an upcoming dividend?
EM Systems dividend dates
Ex Dividend DateJun 27 2024
Dividend Pay DateSep 04 2024
Days until Ex dividend62 days
Days until Dividend pay date131 days

Does EMO pay a reliable dividends?

See EMO dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.